Delivery Order SPE2DR25D7056-SPE2DR26FV8UG
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,157 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML, with performance in Conshohocken, Pennsylvania and completion targeted for December 9, 2025. This non-set-aside award was issued on November 17, 2025, and represents a single delivery order under AmerisourceBergen's larger contract vehicle with the DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency (DLA) awarded a $2,632.00 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine syringes (12 years and up) on November 24, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,718.65 to AmerisourceBergen Drug Corp for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ML syringes. The non-competitive delivery order carries a firm fixed price structure with an ultimate completion date of November 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle that...
- The Defense Logistics Agency awarded a delivery order valued at $2,987.50 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of December 10, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5 mL syringes, with a ceiling value of $2,736.13. This firm fixed-price delivery order, issued on December 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The work is scheduled for completion by January...
- The Defense Logistics Agency awarded a $1,156.93 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML, with completion targeted for January 8, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes in the amount of $1,302.58. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccines (12 years and up) in 0.5ml syringes, with a completion date of January 2, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,684.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine syringes (12 years and up, 0.5 mL). The award, issued on November 18, 2025, is due for completion by December 10, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- SPE2DR25D7056Indefinite Delivery Contract
- SPE2DR25D7056-SPE2DR26FV8UGDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25mL per unit, with a ceiling value of $1,156.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The order is scheduled for completion by January 29, 2026, and represents a task order executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive capability in delivering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. The SPIKEVAX vaccine delivery order reflects the company's role in supporting Department of Defense healthcare requirements and aligns with the Defense Health Agency's medical supply chain operations for pediatric immunization programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/6/26 |